Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00537134 · ClinicalTrials.gov registry record · NA
Trial on Endovascular Aneurysm Management
A NA study, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
- Terminated
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00537134 is a NA study that was terminated before completion, run by Centre hospitalier de l'Université de Montréal (CHUM). The registered enrollment target is 80 participants.
The verdict
NCT00537134, a NA study, was terminated before completion, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
- TERMINATED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The management of patients with unruptured aneurysms is controversial. Patients with unruptured aneurysms may suffer intracranial hemorrhage, but the incidence of this event is still debated. Endovascular treatment can prevent rupture, but involves immediate risks; furthermore, successful treatment does not eliminate all risks. A randomized trial may be the best way to demonstrate the potential benefits of endovascular over conservative management of unruptured aneurysms.
Interventions
- DEVICE Embolization, coiling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2006-04 |
| Est. Completion | 2009-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00537134
The ClinicalTrials.gov registry entry for NCT00537134 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centre hospitalier de l'Université de Montréal (CHUM), which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Embolization, coiling is the first listed.
NCT00537134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00537134 about?
NCT00537134 is a clinical study titled "Trial on Endovascular Aneurysm Management". The management of patients with unruptured aneurysms is controversial. Patients with unruptured aneurysms may suffer intracranial hemorrhage, but the incidence of this event is still debated. Endovascular treatment can prevent rupture, but involves immediate risks; furthermore, successful treatment ...
What is the current status of trial NCT00537134?
This trial is currently terminated. It is a NA study. The enrollment target is 80 participants. The study started on 2006-04. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00537134?
The interventions under investigation include: Embolization, coiling (DEVICE).
Who is sponsoring clinical trial NCT00537134?
This trial is sponsored by Centre hospitalier de l'Université de Montréal (CHUM), which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.